AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cloft, H.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cloft, H.J.

INTERVENTIONAL

HydroCoil for Endovascular Aneurysm Occlusion (HEAL) Study: 3–6 Month Angiographic Follow-Up Results

H.J. Cloft for the HEAL Investigators

Address correspondence to Harry J. Cloft, MD, PhD, Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905; e-mail: cloft.harry{at}mayo.edu

BACKGROUND AND PURPOSE: The HydroCoil Embolic System (HES) was developed reduce recurrences of aneurysms relative to platinum coils. This study was conducted to evaluate the recurrence rate of cerebral aneurysms 3–6 months after treatment with HES.

METHODS: We report the results in 135 cerebral aneurysms treated with HES in a prospective multicenter registry. Angiographic results 3–6 months after treatment were evaluated at a core laboratory. Wide variation in HES utilization within the HydroCoil for Endovascular Aneurysm Occlusion (HEAL) registry (HES representing 5% to 100% of the coil length used) allowed for subgroup analysis with regard to percentage length, last coil used, and packing attenuation in small (<10 mm) aneurysms.

RESULTS: The overall recurrence rate was 38 (28.1%) of 135, which included a number of large, giant, and previously recurrent aneurysms. When HES represented ≥75% of coil length, the recurrence rate was 0 (0%) of 18, whereas with <75% length of HES, the recurrence rate was 16 (23%) of 71 (P = .035). When the final coil deposited was a HES coil, the recurrence rate was 6 (11%) of 53, whereas when the final coil was platinum, the recurrence rate was 10 (29%) of 34 (P = .047). When the packing attenuation was ≥50%, the recurrence rate was 11 (19%) of 59, whereas for packing attenuation <50%, the recurrence rate was 5 (18%) of 28. The packing attenuation calculations were very error-prone.

CONCLUSION: Although the overall recurrence rates for small and large aneurysms in HEAL were no lower than published rates for aneurysms treated with platinum coils, patients treated in HEAL had a reduced recurrence rate when greater than 75% of the coil length used to treat an aneurysm was HES and when the final coil was HES.




This article has been cited by other articles:


Home page
Journal of NeuroInterventional SurgeryHome page
D Fiorella, P Lylyk, I Szikora, M E Kelly, F C Albuquerque, C G McDougall, and P K Nelson
Curative cerebrovascular reconstruction with the Pipeline embolization device: the emergence of definitive endovascular therapy for intracranial aneurysms
JNIS, July 1, 2009; 1(1): 56 - 65.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
D.F. Kallmes, Y.H. Ding, D. Dai, R. Kadirvel, D.A. Lewis, and H.J. Cloft
A Second-Generation, Endoluminal, Flow-Disrupting Device for Treatment of Saccular Aneurysms
AJNR Am. J. Neuroradiol., June 1, 2009; 30(6): 1153 - 1158.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
P.M. White and J. Raymond
Endovascular Coiling of Cerebral Aneurysms Using "Bioactive" or Coated-Coil Technologies: A Systematic Review of the Literature
AJNR Am. J. Neuroradiol., February 1, 2009; 30(2): 219 - 226.
[Abstract] [Full Text] [PDF]


Home page
radtechHome page
A. R. SCHONFELD and M. A McMULLEN
Treatment of Brain Aneurysms
Radiol. Technol., July 1, 2008; 79(6): 515 - 531.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
P.M. White, S.C. Lewis, H. Nahser, R.J. Sellar, T. Goddard, A. Gholkar, and on behalf of the HELPS Trial Collaboration
HydroCoil Endovascular Aneurysm Occlusion and Packing Study (HELPS Trial): Procedural Safety and Operator-Assessed Efficacy Results
AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 217 - 223.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. C. Johnston, C. F. Dowd, R. T. Higashida, M. T. Lawton, G. R. Duckwiler, D. R. Gress, and for the CARAT Investigators
Predictors of Rehemorrhage After Treatment of Ruptured Intracranial Aneurysms: The Cerebral Aneurysm Rerupture After Treatment (CARAT) Study
Stroke, January 1, 2008; 39(1): 120 - 125.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Kadirvel, Y.-H. Ding, D. Dai, D. A. Lewis, H. J. Cloft, and D. F. Kallmes
Molecular Indices of Apoptosis Activation in Elastase-Induced Aneurysms After Embolization With Platinum Coils
Stroke, October 1, 2007; 38(10): 2787 - 2794.
[Abstract] [Full Text] [PDF]